Control of Drosophila wing size by morphogen range and hormonal gating
- Creators
-
Parker, Joseph
-
Struhl, Gary
Abstract
The stereotyped dimensions of animal bodies and their component parts result from tight constraints on growth. Yet, the mechanisms that stop growth when organs reach the right size are unknown. Growth of the Drosophila wing—a classic paradigm—is governed by two morphogens, Decapentaplegic (Dpp, a BMP) and Wingless (Wg, a Wnt). Wing growth during larval life ceases when the primordium attains full size, concomitant with the larval-to-pupal molt orchestrated by the steroid hormone ecdysone. Here, we block the molt by genetically dampening ecdysone production, creating an experimental paradigm in which the wing stops growing at the correct size while the larva continues to feed and gain body mass. Under these conditions, we show that wing growth is limited by the ranges of Dpp and Wg, and by ecdysone, which regulates the cellular response to their signaling activities. Further, we present evidence that growth terminates because of the loss of two distinct modes of morphogen action: 1) maintenance of growth within the wing proper and 2) induced growth of surrounding "pre-wing" cells and their recruitment into the wing. Our results provide a precedent for the control of organ size by morphogen range and the hormonal gating of morphogen action.
Additional Information
© 2020 National Academy of Sciences. Published under the PNAS license. Contributed by Gary Struhl, October 25, 2020 (sent for review August 28, 2020; reviewed by Peter A. Lawrence and Gines Morata). PNAS first published November 30, 2020. We thank Michael O'Connor for Phantom enhancer DNA; Christen Mirth for advice regarding the 20E enzyme-linked immunosorbent assay and the consequences of EcR and Usp RNAi knock-down; Myriam Zecca for the UAS.dpp-GFP transgene; and Myriam Zecca, Andrew Tomlinson, and Rory Coleman and for discussion and critical comments on the manuscript. This work was supported by a Sir Henry Wellcome Postdoctoral Fellowship to J.P. and funding to G.S. from the Ellison Medical Foundation (AG-SS-2823-11), the Howard Hughes Medical Institute, and NIH grants R01 GM113000 and R35 GM127141. Data Availability: All study data are included in the paper and SI Appendix. Author contributions: J.P. and G.S. designed research, performed research, contributed new reagents/analytic tools, analyzed data, and wrote the paper. Reviewers: P.A.L., Medical Research Council Laboratory of Molecular Biology; and G.M., Autonomous University of Madrid. The authors declare no competing interest. This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2018196117/-/DCSupplemental.Attached Files
Published - 31935.full.pdf
Supplemental Material - pnas.2018196117.sapp.pdf
Files
Name | Size | Download all |
---|---|---|
md5:07378e72d498b575771ed48b54c9bf6a
|
2.7 MB | Preview Download |
md5:a7210029d00ca5e5c096db7877270da2
|
8.4 MB | Preview Download |
Additional details
- Eprint ID
- 106850
- DOI
- 10.1073/pnas.2018196117
- Resolver ID
- CaltechAUTHORS:20201201-070314122
- Wellcome Trust
- AG-SS-2823-11
- Ellison Medical Foundation
- Howard Hughes Medical Institute (HHMI)
- R01 GM113000
- NIH
- R35 GM127141
- NIH
- Created
-
2020-12-02Created from EPrint's datestamp field
- Updated
-
2021-11-16Created from EPrint's last_modified field
- Caltech groups
- Division of Biology and Biological Engineering